{"id":"W2072767047","doi":"10.1158/1535-7163.targ-11-b49","title":"Abstract B49: GRN1005 phase I studies: Final results.","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Tolerability; Pharmacokinetics; Immunogenicity; Medicine; Glioma; Brain tumor; Pharmacology; Transcytosis; Paclitaxel; Cancer; Internal medicine; Cancer research; Oncology; Receptor; Antibody; Immunology; Adverse effect; Pathology; Endocytosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002287575,0.0003328486,0.0003046043,0.00006090401,0.0001113233,0.00002294454,0.0003523033,0.0002045448,0.00007252082],"category_scores_gemma":[0.00002940758,0.0003153681,0.0002228066,0.0001486729,0.000190647,0.000007316171,0.0001036458,0.0001907227,0.00002047298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000422568,"about_ca_system_score_gemma":0.0002120893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009190313,"about_ca_topic_score_gemma":0.00008931317,"domain_scores_codex":[0.9982359,0.00005615904,0.0003968391,0.0005786188,0.0002491661,0.0004833411],"domain_scores_gemma":[0.9987676,0.000009000914,0.0001795852,0.0006984237,0.0002117365,0.0001336684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00116262,0.0003347124,0.00004899606,0.00004456592,0.0009192501,0.00001640076,0.0009994246,0.00003497661,0.9076976,0.0001752993,0.004348662,0.08421755],"study_design_scores_gemma":[0.002972467,0.0002724633,0.0003798867,0.00002591054,0.0001647215,0.000007955789,0.0001854255,0.000009065628,0.4510123,0.000213912,0.5443858,0.0003700954],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8657961,0.1195098,0.002064042,0.0004727386,0.003736157,0.0005620268,0.000306046,0.00007871877,0.007474377],"genre_scores_gemma":[0.9680359,0.02371727,0.0011013,0.004029673,0.001596118,0.0001302084,0.00009800577,0.00009377653,0.001197687],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5400371,"threshold_uncertainty_score":0.9999298,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09631823802331448,"score_gpt":0.3538036902613952,"score_spread":0.2574854522380808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}